10 likes | 115 Views
Figure 1 Results of cardiac function tests in the phase III trial of lapatinib plus capecitabine for metastatic breast cancer. Permission obtained from Geyer CE et al . (2006) Lapatinib plus capecitabine for HER2-positive advanced breast cancer. N Engl J Med 355: 2733–2743.
E N D
Figure 1 Results of cardiac function tests in the phase III trial of lapatinib plus capecitabine for metastatic breast cancer Permission obtained from Geyer CE et al. (2006) Lapatinib plus capecitabine for HER2-positive advanced breast cancer. N Engl J Med 355: 2733–2743 Cameron DA and Stein S (2008) Drug Insight: intracellular inhibitors of HER2—clinical development of lapatinib in breast cancer Nat Clin Pract Oncol doi:10.1038/ncponc1156